Join Novalix at the ACSMEDI-EFMC Medicinal Chemistry Frontiers in Chicago, IL. This event is co-organized by ACSMEDI (Division of Medicinal Chemistry of the American Chemical Society), and EFMC (European Federation for Medicinal Chemistry and Chemical Biology).
“Combining DEL, AI, and medicinal chemistry: the winning synergy in drug discovery”
We are excited to announce that Dr Dhoha Triki, Senior Scientist in Computational Chemistry, will deliver an oral communication entitled: “Combining DEL, AI, and medicinal chemistry: the winning synergy in drug discovery”:
- on May 13, 2025
at 12:00 p.m.
in Session 2 – Artificial Intelligence in Drug Discovery
Ref. OC03
More details on Medicinal Chemistry Frontiers
Renowned speakers will present their latest results and the emerging trends in medicinal chemistry and drug discovery. ACSMEDI-EFMC Medicinal Chemistry Frontiers Meeting attracts experts, researchers and early career trainees in drug discovery and development, such as medicinal and synthetic chemists, and scientists in computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.
– high quality plenary lectures
– sessions on key topics
– oral communications
– an extensive social program to maximize networking opportunities
– a poster session
– a commercial exhibition
Meet us at our booth #8
Come and visit us at booth No. 8 during Medicinal Chemistry Frontiers.
Just contact us to set up a meeting and catch up!
Event
Visit websiteDate
From
May 12, 2025
to
May 15, 2025
Location
Chicago, IL, USA
Attendees
Frank Moffatt, PhD
Senior Director of Business Development
Dhoha Triki, PhD
Senior Scientist Computational Chemistry
Felix von Haniel
SVP Business Development and Marketing